Elliott Builds Stake in Life-Science Firm Bio-Rad, WSJ Says
Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperfoming stock price, the Wall Street Journal reported, citing people familiar with the matter.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.